AI diagnosis
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
It uses a competitive learning approach against unlabelled data.
It is a simple and low-cost model that promotes the early detection of the condition.
The approval marks its entry into the $160-billion US medical device market.
Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.
It seeks to raise the number of skin checks in Australia by a quarter.
Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.
Also, a new online repository of health and wellness knowledge has been launched in India.
The clinical trial with Huntsville Heart Center is expected to be completed by October.
Also, Intuitive India releases its mobile app for surgeons using the da Vinci RAS system.